Clinical Trials

Sustained Release Lidocaine for the Treatment of Postoperative Pain - Clinical Trial

ST-CP-201-Sustained Release Lidocaine for the Treatment of Postoperative Pain

The ST-CP-201 Clinical trial is being conducted in subjects that are scheduled for pelvic surgery (inguinal incision, circumcision, scrotal surgery or hemorrhoidectomy). The study is being conducted at 2 centers in Vancouver and is expected to enroll approximately 60 participants. The purpose of the study is to determine if a single injection of ST-01 is safe and effective in reducing post-operative pain and opioid use as compared to a control group who receive the current standard of care.

Learn more about the study here.

Find a Location

ST-CP-201-Sustained Release Lidocaine for the Treatment of Postoperative Pain

British Columbia

Vancouver Prostate Centre

Vancouver, British Columbia, Canada, V5Z 1M9

Contact: Clinical Trials Coordinator, 604-875-4111 ext. 67898

clinic@ubcurology.com

Principal Investigator: Ryan Flannigan, MD

Department of Surgery,
St. Paul’s Hospital

Vancouver, British Columbia, Canada V6Z 1Y6

Contact: ST-CP-201 Study, Clinical Trials Coordinator

604-682-2344 ext. 66040

mobermayer@providencehealth.bc.ca

Principal Investigator:  Dr. Amandeep Ghuman

Verified by MonsterInsights